Breaking: Judgment In Regeneron v. Mylan (Aflibercept) BPCIA

As previously reported by Big Molecule Watch, trial in Regeneron's BPCIA case against Biocon regarding Biocon's proposed aflibercept biosimilar concluded on June 15, 2023 in the Northern District of West Virginia.

Related Keywords

West Virginia , United States , Samsung Bioepis , Biocon , Big Molecule Watch , Northern District , Mondaq , Aflibercept , Eylea , Litigation , Dylan , Regeneron , Regeneronv Mylan , Food , Drugs , Healthcare , Life Sciences , Iotechnology Amp Nanotechnology , Intellectual Property , Patent , ,